CESR has published a call for evidence on which classification and identification standards are appropriate for OTC derivative instruments. It is particularly interested in instruments which Member States have used Recital 45 of MiFID to bring within the scope of transaction reporting requirements. It wants the evidence to build into its Transaction Reporting Exchange Mechanism (TREM). It asks for comments by 27 February.